UK volunteers to receive Moderna Omicron COVID-19 booster vaccine in clinical study | NIHR
Boosters give 70%-75% protection against mild disease from omicron, UK says
The U.K. approved omicron-specific booster shots. They're coming to the U.S. soon : NPR
Booster blitz: UK races to get ahead of surging omicron – KGET 17
Britain expands COVID booster programme as eight more Omicron cases found | Reuters
U.K. Approves Covid-19 Booster Shot Aimed at Omicron - WSJ
Covid booster shots up to 75% effective against Omicron, UK study finds
High confidence' Omicron is less severe in UK - BBC News
UK first to approve Omicron COVID shot with Moderna nod | Reuters
Covid: UK in a 'race between virus and vaccine' over Omicron, says Sajid Javid - BBC News
UK 'turbocharges' booster vaccination as Omicron becomes dominant – EURACTIV.com
Covid booster restores vaccine protection lost against omicron variant, U.K. study finds
Boosters vital to mitigate impact of Omicron, but may lose some effectiveness | Imperial News | Imperial College London
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial - The Lancet Infectious Diseases
UK regulator OKs Moderna COVID booster that targets Omicron - Los Angeles Times
Get Boosted Now - GOV.UK
UK announces first Omicron death as Britons rush for booster jabs | Coronavirus pandemic News | Al Jazeera
Omicron booster: UK becomes first nation to approve vaccine that targets two Covid-19 variants | CNN
Early U.K. Data: Two Vax Doses Don't Cut It Against Omicron | MedPage Today
Covid booster shots up to 75% effective against Omicron, UK study finds
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Covid booster 88% effective against hospital treatment with Omicron - BBC News
COVID-19 tracker: Omicron booster nods expected Wednesday
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
UK Volunteers to receive Moderna Omicron COVID-19 booster vaccine in study led by St George's, University of London - St George's University Hospitals NHS Foundation Trust
